Monday, June 15, 2026

Imeroprubart vs. Batoclimab: Which Treatment Will Revolutionize Graves’ Disease Management?

HanAll Biopharma's Imeroprubart targets Graves' disease, showing promise with IgG suppression and user-friendly auto-injector delivery.

Samsung Display Signals Readiness to Supply Foldable OLEDs, MicroLEDs to Apple and Tesla

Samsung Display's CEO Lee Chung discusses next-gen displays for Apple and Tesla, addressing tariffs' impact on the market.

Tag: taeyeon

No posts to display

Top News

- Our Sponsors Ad -

Follow us